259 related articles for article (PubMed ID: 28237171)
1. Atypical transient subretinal exudation following photodynamic therapy for chronic central serous retinopathy: a case report.
Al-Awadi A; Mandelcorn ED; Somani S
Can J Ophthalmol; 2017 Feb; 52(1):e38-e41. PubMed ID: 28237171
[No Abstract] [Full Text] [Related]
2. Efficacy of reduced-fluence photodynamic therapy for central serous chorioretinopathy associated with combined serous retinal detachment and fovea-involving pigment epithelial detachment.
Arf S; Hocaoglu M; Sayman Muslubas I; Karacorlu M
Int Ophthalmol; 2017 Jun; 37(3):483-489. PubMed ID: 27392913
[TBL] [Abstract][Full Text] [Related]
3. Detection of morphologic alterations by spectral-domain optical coherence tomography before and after half-dose verteporfin photodynamic therapy in chronic central serous chorioretinopathy.
Shinojima A; Kawamura A; Mori R; Fujita K; Yuzawa M
Retina; 2011 Oct; 31(9):1912-20. PubMed ID: 21952105
[TBL] [Abstract][Full Text] [Related]
4. CLINICAL FEATURES OF FLAT IRREGULAR PIGMENT EPITHELIAL DETACHMENT ASSOCIATED WITH CHOROIDAL NEOVASCULARIZATION IN CHRONIC CENTRAL SEROUS CHORIORETINOPATHY.
Guo J; Tang W; Liu W; Chang Q; Xu G
Retina; 2021 Jan; 41(1):199-207. PubMed ID: 32251241
[TBL] [Abstract][Full Text] [Related]
5. PHOTODYNAMIC THERAPY FOR SYMPTOMATIC SUBFOVEAL RETINAL PIGMENT EPITHELIAL DETACHMENT IN CENTRAL SEROUS CHORIORETINOPATHY: Outcomes and Prognostic Factors.
Hwang S; Kang SW; Kim SJ; Jang JW; Kim KT
Retina; 2019 Jun; 39(6):1117-1124. PubMed ID: 29517581
[TBL] [Abstract][Full Text] [Related]
6. Half-Fluence Photodynamic Therapy for Chronic Central Serous Chorioretinopathy: Predisposing Factors for Visual Acuity Outcomes.
Matušková V; Vysloužilová D; Uher M
Semin Ophthalmol; 2018; 33(5):690-699. PubMed ID: 29252091
[TBL] [Abstract][Full Text] [Related]
7. Isolated pigment epithelium detachment: evidence for relation to central serous chorioretinopathy and effect of photodynamic therapy.
Arif F; Pryds A; Larsen M
Acta Ophthalmol; 2018 Dec; 96(8):821-827. PubMed ID: 30246489
[TBL] [Abstract][Full Text] [Related]
8. Photodynamic therapy in chronic central serous chorioretinopathy with subretinal fluid outside the fovea.
van Dijk EHC; Dijkman G; Boon CJF
Graefes Arch Clin Exp Ophthalmol; 2017 Oct; 255(10):2029-2035. PubMed ID: 28674835
[TBL] [Abstract][Full Text] [Related]
9. Optical Coherence Tomography Angiography Findings in Chronic Central Serous Chorioretinopathy After Photodynamic Therapy.
Tang PH; Shields R; Silva RA
Ophthalmic Surg Lasers Imaging Retina; 2019 Jan; 50(1):25-32. PubMed ID: 30640392
[TBL] [Abstract][Full Text] [Related]
10. Retinal sensitivity after selective retina therapy (SRT) on patients with central serous chorioretinopathy.
Yasui A; Yamamoto M; Hirayama K; Shiraki K; Theisen-Kunde D; Brinkmann R; Miura Y; Kohno T
Graefes Arch Clin Exp Ophthalmol; 2017 Feb; 255(2):243-254. PubMed ID: 27497611
[TBL] [Abstract][Full Text] [Related]
11. Photodynamic therapy for chronic pigment epithelial detachment in central serous chorioretinopathy.
Chang MA; Bressler SB
Can J Ophthalmol; 2009 Apr; 44(2):221-2. PubMed ID: 19491970
[No Abstract] [Full Text] [Related]
12. Clinical characteristics of chronic central serous chorioretinopathy patients with insufficient response to reduced-settings photodynamic therapy.
van Rijssen TJ; van Dijk EHC; Dijkman G; Boon CJF
Graefes Arch Clin Exp Ophthalmol; 2018 Aug; 256(8):1395-1402. PubMed ID: 29732468
[TBL] [Abstract][Full Text] [Related]
13. Retinal pigment epithelial tear after half fluence PDT for serous pigment epithelial detachment in central serous chorioretinopathy.
Kim SW; Oh J; Oh IK; Huh K
Ophthalmic Surg Lasers Imaging; 2009; 40(3):300-3. PubMed ID: 19485297
[TBL] [Abstract][Full Text] [Related]
14. Microrip of Retinal Pigment Epithelium in Central Serous Chorioretinopathy.
Ranjan R; Agarwal M; Verma N
JAMA Ophthalmol; 2020 Jun; 138(6):e193120. PubMed ID: 32525538
[No Abstract] [Full Text] [Related]
15. Exacerbation of central serous chorioretinopathy following PASCAL photocoagulation.
Yang HS; Park SH
Can J Ophthalmol; 2013 Jun; 48(3):e42-3. PubMed ID: 23769790
[No Abstract] [Full Text] [Related]
16. Photodynamic therapy for variant central serous chorioretinopathy: efficacy and side effects.
Gupta B; Mohamed MD
Ophthalmologica; 2011; 225(4):207-10. PubMed ID: 21325872
[TBL] [Abstract][Full Text] [Related]
17. Structural and Functional Outcomes in Chronic Central Serous Chorioretinopathy Treated with Photodynamic Therapy.
Cidad P; González E; Asencio M; García J
Korean J Ophthalmol; 2015 Oct; 29(5):331-5. PubMed ID: 26457039
[TBL] [Abstract][Full Text] [Related]
18. Modified Photodynamic Therapy Treatment of Central Serous Chorioretinopathy.
Putnam CM; Vang SS
Optom Vis Sci; 2016 Jul; 93(7):760-71. PubMed ID: 27058592
[TBL] [Abstract][Full Text] [Related]
19. ACUTE EXACERBATION OF CHRONIC CENTRAL SEROUS CHORIORETINOPATHY AT THE SITE OF A RETINAL PIGMENT EPITHELIUM APERTURE.
Abramowicz S; Pasteels B; Postelmans L
Retin Cases Brief Rep; 2024 Mar; 18(2):206-210. PubMed ID: 36007174
[TBL] [Abstract][Full Text] [Related]
20. Relapsing Pigment Epithelial Detachment in Central Serous Chorioretinopathy After Dilated Eye Examination.
German O; Jampol LM
JAMA Ophthalmol; 2020 Oct; 138(10):1106-1107. PubMed ID: 32880606
[No Abstract] [Full Text] [Related]
[Next] [New Search]
